From: Perioperative care of congenital adrenal hyperplasia – a disparity of physician practices in Canada
Demographics, n (%) | Combined (N = 86) | Anesthesiologists (n = 49, 57%) | Endocrinologists (n = 37, 43%) | P-valuea |
---|---|---|---|---|
Age | ||||
25–35 years | 10 (11.6) | 1 (2.0) | 9 (24.3) | 0.002 |
36–50 years | 41 (47.7) | 23 (46.9) | 18 (48.7) | |
> 50 years | 35 (40.7) | 25 (51.0) | 10 (27.0) | |
Sex | ||||
Male | 39 (46.4) | 30 (63.8) | 9 (24.3) | 0.0003 |
Female | 45 (53.6) | 17 (36.2) | 28 (75.7) | |
Practice characteristics, n (%) | ||||
Practice type | ||||
University/ teaching | 76 (88.4) | 42 (85.7) | 34 (91.9) | 0.50 |
Other | 10 (11.6) | 7 (14.3) | 3 (8.1) | |
Years in practice | ||||
< 5 | 13 (15.9) | 0 | 13 (39.4) | < 0.0001 |
5–10 | 17 (20.7) | 12 (24.5) | 5 (15.1) | |
11–15 | 10 (12.2) | 7 (14.3) | 3 (9.1) | |
> 15 | 42 (51.2) | 30 (61.2) | 12 (36.4) | |
Congenital adrenal hyperplasia in practice | ||||
Administer stress dose steroids for cystoscopy | ||||
Yes | 55 (65.5) | 21 (44.7) | 34 (91.9) | < 0.0001 |
No | 29 (34.5) | 26 (55.3) | 3 (8.1) | |
Concerned about repeated single high dose steroids | ||||
Yes | 22 (26.2) | 17 (36.2) | 5 (13.5) | 0.019 |
No | 62 (73.8) | 30 (63.8) | 32 (86.5) | |
Consult opposite specialty | ||||
Always | 20 (23.3) | 14 (28.6) | 6 (16.2) | 0.16 |
Frequently | 18 (20.9) | 12 (24.5) | 6 (16.2) | |
Occasionally | 25 (29.1) | 14 (28.6) | 11 (29.7) | |
Never | 23 (26.7) | 9 (18.4) | 14 (37.8) | |
See endocrinology before surgery | ||||
Sometimes | 8 (9.5) | 5 (10.6) | 3 (8.1) | 0.99 |
Yes | 76 (90.5) | 42 (89.4) | 34 (91.9) | |
Follow guidelines for stress dose decision | ||||
Yes | 56 (65.1) | 25 (51.0) | 31 (83.8)b | 0.001 |
No | 30 (34.9) | 24 (49.0) | 6 (16.2) |